Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Rupar, Kaja

Class:IdPerson:9697906
_displayNameRupar, Kaja
_timestamp2020-08-21 14:01:48
created[InstanceEdit:9697910] Rothfels, Karen, 2020-08-21
firstnameKaja
initialK
surnameRupar
(author)[LiteratureReference:9697909] Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
[LiteratureReference:9706052] ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
[Change default viewing format]
No pathways have been reviewed or authored by Rupar, Kaja (9697906)